BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

477 related articles for article (PubMed ID: 25825281)

  • 1. Atherosclerosis in rheumatoid arthritis: is it all about inflammation?
    Skeoch S; Bruce IN
    Nat Rev Rheumatol; 2015 Jul; 11(7):390-400. PubMed ID: 25825281
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting inflammation as a therapeutic strategy in accelerated atherosclerosis in rheumatoid arthritis.
    Full LE; Monaco C
    Cardiovasc Ther; 2011 Aug; 29(4):231-42. PubMed ID: 20553292
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Rheumatoid arthritis, inflammation, and atherosclerosis].
    Hürlimann D; Enseleit F; Ruschitzka F
    Herz; 2004 Dec; 29(8):760-8. PubMed ID: 15599672
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rheumatoid Arthritis: Atherosclerosis Imaging and Cardiovascular Risk Assessment Using Machine and Deep Learning-Based Tissue Characterization.
    Khanna NN; Jamthikar AD; Gupta D; Piga M; Saba L; Carcassi C; Giannopoulos AA; Nicolaides A; Laird JR; Suri HS; Mavrogeni S; Protogerou AD; Sfikakis P; Kitas GD; Suri JS
    Curr Atheroscler Rep; 2019 Jan; 21(2):7. PubMed ID: 30684090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New insights to the mechanisms underlying atherosclerosis in rheumatoid arthritis.
    Mahmoudi M; Aslani S; Fadaei R; Jamshidi AR
    Int J Rheum Dis; 2017 Mar; 20(3):287-297. PubMed ID: 28205331
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential effect of anti-inflammatory treatment on reducing the cardiovascular risk in rheumatoid arthritis.
    Chighizola C; Schioppo T; Ingegnoli F; Meroni PL
    Curr Vasc Pharmacol; 2012 Sep; 10(5):639-46. PubMed ID: 22272912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiovascular risk and rheumatoid arthritis: from mechanisms of atherosclerosis to therapeutic approach.
    Jurcuţ C; Jurcuţ R; Tănăsescu C
    Rom J Intern Med; 2004; 42(4):659-69. PubMed ID: 16366138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of inflammation in atherosclerosis associated with rheumatoid arthritis.
    Libby P
    Am J Med; 2008 Oct; 121(10 Suppl 1):S21-31. PubMed ID: 18926166
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiovascular disease in rheumatoid arthritis.
    Sen D; González-Mayda M; Brasington RD
    Rheum Dis Clin North Am; 2014 Feb; 40(1):27-49. PubMed ID: 24268008
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiovascular risk in rheumatoid arthritis: effects of anti-TNF drugs.
    Avouac J; Allanore Y
    Expert Opin Pharmacother; 2008 May; 9(7):1121-8. PubMed ID: 18422470
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiovascular risk in rheumatoid arthritis: how to lower the risk?
    van Breukelen-van der Stoep DF; Klop B; van Zeben D; Hazes JM; Castro Cabezas M
    Atherosclerosis; 2013 Nov; 231(1):163-72. PubMed ID: 24125429
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cardiovascular disorders in rheumatoid arthritis].
    Morović-Vergles J
    Reumatizam; 2008; 55(2):53-6. PubMed ID: 19024275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cardiovascular Complications of Rheumatoid Arthritis: Prevalence and Pathogenesis].
    Krougly LB; Fomicheva OA; Karpov YA; Popkova TV; Novikova DS; Nasonov EL
    Kardiologiia; 2016 Jun; 56(6):89-95. PubMed ID: 28290854
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rheumatoid Arthritis Pharmacotherapies: Do They Have Anti-Atherosclerotic Activity?
    Giles JT
    Curr Rheumatol Rep; 2016 May; 18(5):27. PubMed ID: 27032790
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Atherosclerosis and rheumatoid arthritis].
    Löwenhoff T; Głuszko P
    Przegl Lek; 2005; 62(12):1506-9. PubMed ID: 16786783
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rheumatoid arthritis: model of systemic inflammation driving atherosclerosis.
    Ku IA; Imboden JB; Hsue PY; Ganz P
    Circ J; 2009 Jun; 73(6):977-85. PubMed ID: 19430165
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cardiovascular diseases in rheumatoid arthritis].
    Popkova TV; Khelkovskaia AN; Mach ES; Aleksandrova EN; Novikov AA; Novikova DS; Nasonov EL
    Ter Arkh; 2007; 79(5):9-14. PubMed ID: 17672067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of a treat-to-target intervention of cardiovascular risk factors on subclinical and clinical atherosclerosis in rheumatoid arthritis: a randomised clinical trial.
    Burggraaf B; van Breukelen-van der Stoep DF; de Vries MA; Klop B; Liem AH; van de Geijn GM; van der Meulen N; Birnie E; van der Zwan EM; van Zeben J; Castro Cabezas M
    Ann Rheum Dis; 2019 Mar; 78(3):335-341. PubMed ID: 30610067
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiovascular risk in rheumatoid arthritis: recent advances in the understanding of the pivotal role of inflammation, risk predictors and the impact of treatment.
    Choy E; Ganeshalingam K; Semb AG; Szekanecz Z; Nurmohamed M
    Rheumatology (Oxford); 2014 Dec; 53(12):2143-54. PubMed ID: 24907149
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atherosclerotic disease is increased in recent-onset rheumatoid arthritis: a critical role for inflammation.
    Hannawi S; Haluska B; Marwick TH; Thomas R
    Arthritis Res Ther; 2007; 9(6):R116. PubMed ID: 17986352
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.